[HTML][HTML] Beta-blockers in cirrhosis: Evidence-based indications and limitations
Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in
the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in …
the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in …
[HTML][HTML] Managing liver cirrhotic complications: Overview of esophageal and gastric varices
CRA Lesmana, M Raharjo, RA Gani - Clinical and molecular …, 2020 - ncbi.nlm.nih.gov
Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is
associated with serious complications, such as variceal bleeding that may increase …
associated with serious complications, such as variceal bleeding that may increase …
肝硬化门静脉高压食管胃静脉曲张出血的防治指南.
徐小元， 唐承薇， 令狐恩强 - Journal of Clinical Hepatology …, 2023 - search.ebscohost.com
中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会 Page 1 !,-./0! 肝
硬化门静脉高压食管胃静脉曲张出血的防治指南 中华医学会肝病学分会,中华医学会消化病学 …
硬化门静脉高压食管胃静脉曲张出血的防治指南 中华医学会肝病学分会,中华医学会消化病学 …
Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC
CJ Daniels, EA Bradley, MJ Landzberg… - Journal of the American …, 2017 - jacc.org
Over the past decade, as the majority of patients with single ventricle anatomy who have
undergone the Fontan operation reach adulthood, a newly recognized disease process …
undergone the Fontan operation reach adulthood, a newly recognized disease process …
S2k-leitlinie gastrointestinale blutung
M Goetz, M Anders, E Biecker… - Zeitschrift für …, 2017 - thieme-connect.com
Diese interdisziplinäre Leitlinie unter Leitung der DGVS und Beteiligung benachbarter
Fachgesellschaften fasst die wichtigsten Aspekte zur Versorgung von Patienten mit …
Fachgesellschaften fasst die wichtigsten Aspekte zur Versorgung von Patienten mit …
Beta adrenergic blockade and decompensated cirrhosis
T Reiberger, M Mandorfer - Journal of hepatology, 2017 - Elsevier
Non-selective betablockers (NSBBs) remain the cornerstone of medical treatment of portal
hypertension. The evidence for their efficacy to prevent variceal bleeding is derived from …
hypertension. The evidence for their efficacy to prevent variceal bleeding is derived from …
Prevention and management of gastroesophageal varices
YS Seo - Clinical and molecular hepatology, 2017 - pmc.ncbi.nlm.nih.gov
Bleeding from gastroesophageal varices is a serious complication in patients with liver
cirrhosis and portal hypertension. Although there has been significance improvement in the …
cirrhosis and portal hypertension. Although there has been significance improvement in the …
[HTML][HTML] KASL clinical practice guidelines for liver cirrhosis: varices, hepatic encephalopathy, and related complications
Korean Association for the Study of the … - Clinical and …, 2020 - ncbi.nlm.nih.gov
Clin Mol Hepatol Volume_26 Number_2 April 2020 https://doi. org/10.3350/cmh. 2019.0010
n clinical practice. Therefore, these revised guidelines for the treatment of varices and HE …
n clinical practice. Therefore, these revised guidelines for the treatment of varices and HE …
Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial
A Bhardwaj, CK Kedarisetty, C Vashishtha… - Gut, 2017 - gut.bmj.com
Background and aims Carvedilol is effective in the primary prophylaxis for large
oesophageal varices. We investigated its use in preventing progression of small to large …
oesophageal varices. We investigated its use in preventing progression of small to large …
Beta blockers and cirrhosis, 2016
M Mandorfer, T Reiberger - Digestive and Liver Disease, 2017 - Elsevier
To date, non-selective beta blockers (NSBBs) are a cornerstone in the treatment of portal
hypertension. During the last years, our understanding of the potential benefits of early …
hypertension. During the last years, our understanding of the potential benefits of early …